Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Asian Journal of Surgery
|
November 9, 2024
Intraoperative electron beam radiotherapy combined with gemcitabine and PD-L1 inhibitors for unresectable pancreatic cancer: Report of 3 cases
Deyuan Zhong, Yuxin Liang, Hongtao Yan, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 20, 2021
Mixed Adenoneuroendocrine Carcinoma of the Gallbladder
Zilong Zhang, Deyuan Zhong, Tianhang Feng, et al.
Oncology Letters
|
May 8, 2026
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with vascular invasion: A systematic review and meta-analysis
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Journal of Hepatocellular Carcinoma
|
June 22, 2026
Tumor-Associated Macrophages in Hepatocellular Carcinoma: From Ontogeny and Heterogeneity to Immune Evasion and Therapeutic Targeting
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Technology in Cancer Research & Treatment
|
February 5, 2026
Prognostic Value of the Ratio of Interleukin-2 and Interleukin-10 in Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Therapy
Deyuan Zhong, Yuxin Liang, Yuhao Su, et al.
Frontiers in Immunology
|
September 12, 2025
Efficacy and safety of postoperative adjuvant HAIC combining lenvatinib with or without PD-1 inhibitors in solitary large HCC: A multicenter retrospective study
Yuxin Liang, Ming Wang, Deyuan Zhong, et al.
BMC Cancer
|
March 7, 2025
Efficacy and safety of postoperative adjuvant HAIC with FOLFOX combining PD-1 inhibitors in HCC patients with microvascular invasion: a propensity score matching analysis
Yuxin Liang, Deyuan Zhong, Jin Shang, et al.
BMC Cancer
|
March 20, 2025
Construction and validation of a novel liver function-tumor burden-inflammation-nutrition (LTIN) score for HCC patients underwent hepatectomy
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Frontiers in Immunology
|
May 8, 2026
TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Journal of Translational Medicine
|
June 19, 2026
S-propargyl-cysteine remodels the HCC microenvironment and potentiates anti-PD-1 therapy through CSE/H<sub>2</sub>S-linked vascular and immune reprogramming
Yuxin Liang, Deyuan Zhong, Hongtao Yan, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Asian Journal of Surgery
|
November 9, 2024
Intraoperative electron beam radiotherapy combined with gemcitabine and PD-L1 inhibitors for unresectable pancreatic cancer: Report of 3 cases
Deyuan Zhong, Yuxin Liang, Hongtao Yan, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 20, 2021
Mixed Adenoneuroendocrine Carcinoma of the Gallbladder
Zilong Zhang, Deyuan Zhong, Tianhang Feng, et al.
Oncology Letters
|
May 8, 2026
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with vascular invasion: A systematic review and meta-analysis
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Journal of Hepatocellular Carcinoma
|
June 22, 2026
Tumor-Associated Macrophages in Hepatocellular Carcinoma: From Ontogeny and Heterogeneity to Immune Evasion and Therapeutic Targeting
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Technology in Cancer Research & Treatment
|
February 5, 2026
Prognostic Value of the Ratio of Interleukin-2 and Interleukin-10 in Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Therapy
Deyuan Zhong, Yuxin Liang, Yuhao Su, et al.
Frontiers in Immunology
|
September 12, 2025
Efficacy and safety of postoperative adjuvant HAIC combining lenvatinib with or without PD-1 inhibitors in solitary large HCC: A multicenter retrospective study
Yuxin Liang, Ming Wang, Deyuan Zhong, et al.
BMC Cancer
|
March 7, 2025
Efficacy and safety of postoperative adjuvant HAIC with FOLFOX combining PD-1 inhibitors in HCC patients with microvascular invasion: a propensity score matching analysis
Yuxin Liang, Deyuan Zhong, Jin Shang, et al.
BMC Cancer
|
March 20, 2025
Construction and validation of a novel liver function-tumor burden-inflammation-nutrition (LTIN) score for HCC patients underwent hepatectomy
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Frontiers in Immunology
|
May 8, 2026
TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Journal of Translational Medicine
|
June 19, 2026
S-propargyl-cysteine remodels the HCC microenvironment and potentiates anti-PD-1 therapy through CSE/H<sub>2</sub>S-linked vascular and immune reprogramming
Yuxin Liang, Deyuan Zhong, Hongtao Yan, et al.
Page
of 4